-
Most Recent
Search Results
240 results for myx
What’s the Right Asset Mix for My Portfolio?
It may seem tricky to figure out what types of investments to choose, but a little homework goes a long way. Here’s a start.
The Market Has Changed… Have You?
Stock market volatility is rising as algorithms react instantly to global events, forcing investors to rethink traditional strategies.
CarMax Is Slashing Prices, Making KMX Stock a Rough Ride
CarMax earnings were mixed at best, throwing KMX stock under the bus again.
Nvidia’s Earnings Signal a Shift in AI Expectations
Today, my InvestorPlace colleague Louis Navellier is joining us to explore what Nvidia’s blowout results reveal about where the AI boom is headed next.
CarMax Earnings: KMX Stock Falls 5% On Mixed Q1 Results
CarMax earnings on Friday have KMX stock lower after the company reported mixed revenue and EPS results for the first quarter of fiscal 2021.
The AI Boom Is Running Into Physical Limits
AI bottlenecks drive the biggest winners. After GPUs and networking, new shortages may shape the next phase of the AI boom.
AI’s Next Bottlenecks Could Mint New Millionaires
In this guest essay below, Eric Fry explains how the first major bottleneck of the AI boom – a shortage of computing power – helped…
C3.AI Generates Big Growth, But Isn’t a Buy Yet
AI stock is worth watching though, as it powers technological innovation. A calmer market or higher earnings could make it a buy.
GEVO Lands a Big Client But Isn’t a Buy Yet
Delta is working with Gevo for a greener tomorrow, but until the agreement meaningfully boosts its financials, GEVO stock isn’t quite a buy.
C3.AI Just Added an Important New Board Member
The latest addition to the board is positive news for AI stock. However, earnings still need to improve before investors pick up shares.
IonQ Is an Interesting Company But Not a Buy Now
IONQ stock has had a wild ride since going public in 2021. It has fascinating tech but it’s better to wait and see on this…
Clover Health’s Earnings Losses Make It One to Avoid for Now
CLOV stock should not be bought until it has positive earnings. The company has good growth to report but needs earnings to lower the risk.
Pump the Breaks on NIO Stock Until the Risks Subside
NIO stock has already exponentially advanced and it has too much risk at these prices. Here’s why you should avoid it for now.
8 – 10 of 240 results